Prevention of increases in blood pressure and left ventricular mass and remodeling of resistance arteries in young New Zealand genetically hypertensive rats: The effects of chronic treatment with valsartan, enalapril and felodipine

Journal of Vascular Research

Volumn 37, Issue 2, 2000, Pages 134-145

  Ledingham, Janet M ^a   Phelan, Edward L ^a   Cross, Marie A ^a   Laverty, Richard ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cardiac hypertrophy; Enalapril; Felodipine; Genetically hypertensive rat; Remodeling; Resistance arteries; Valsartan

Indexed keywords

ENALAPRIL; FELODIPINE; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HYPERTENSION; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; STEREOLOGY; SYSTOLIC BLOOD PRESSURE;

EID: 0034083556     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025724     Document Type: Article

References (43)

1. Folkow B: Physiological aspects of primary hypertension. Physiol Rev 1982;62:347-504.
2. Schiffrin EL, Deng LY, Larochelle P: Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994;23:83-91.
3. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ: Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25(pt 1):474-481.
4. Korsgaard N, Christensen KL, Mulvany MJ: Cellular morphology in mesenteric resistance vessels from antihypertensive treated spontaneously hypertensive rats. Basic Res Cardiol 1991:86(suppl 1):33-41.
5. Ledingham JM, Phelan EL, Cross M, Laverty R, Millar JA: Remodelling of resistance arteries by treatment with enalapril in the New Zealand genetically hypertensive (GH) rat. Clin Exp Pharmacol Physiol 1994;21:235-237.
6. Heagherty AM, Aalkjaer C, Bund SJ. Korsgaard N. Mulvany MJ: Small artery structure in hypertension: Dual process of remodeling and growth. Hypertension 1993;21:391-397.
7. Rizzoni D, Muicsan ML, Porteri E, Castellano M, Zulu G, Salvetti M, Minteduro C, Agabiti Rosei E: Effect of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens 1997;15:197-204.
8. Ledingham JM, Laverty R: The long-term effects of treatment with enalapril on structure of mesenteric resistance arteries in New Zealand genetically hypertensive rats. Clin Exp Pharmacol Physiol 1995;22(suppl 1):S350-S352.
9. Ledingham JM, Laverty R: Remodelling of resistance arteries in genetically hypertensive rats by treatment with valsartan, an angiotensin II receptor antagonist. Clin Exp Pharmacol Physiol 1996;23:576-578.
10. Lee RMKW, Berecek KH, Tsoporis J, McKenzie R, Triggle CR: Prevention of hypertension and vascular changes by captopril treatment. Hypertension 1991; 17:141-150.
11. Lundin SA, Hallbäck-Nordlander MIL: Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats. J Hypertens 1984;2:11-18.
12. Oddie CJ, Dilley RJ, Kanellakis P, Bobik A: Chronic angiotensin II type receptor antagonism in genetic hypertension: Effects on vascular structure and reactivity. J Hypertens 1993; 11:717-724.
13. Porteri E, Rizzoni D, Castellano M, Bettoni G, Muiesan ML, Salvetti M, Quartaroli M, Gaviraghi G, Agabiti Rosei E: Structural changes of small resistance arteries in spontaneously hypertensive rats after treatment with various doses of lacidipine. J Hypertens 1997;15:619-625.
14. Rizzoni D, Castellano M. Porteri E, Bettoni G, Muiesan ML, Cinelli A, Agabiti Rosei E: Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Hypertension 1995;26:118-123.
15. Simpson FO, Phelan EL, Ledingham JM, Millar JA: Hypertension in the genetically hypertensive (GH) strain: in Ganten D. de Jong W (eds): Handbook of Hypertension, vol 16: Experimental and Genetic Models of Hypertension. Amsterdam, Elsevier, 1994, pp 228-271.
16. Ledingham JM. Millar JA: Stereological studies on mesenteric resistance artery structure in NZ genetically hypertensive rat (GH) and their control (N) rats. Clin Exp Pharmacol Physiol 1993;20:359-361.
17. Mulvany MJ, Baumbach GL, Alkjaer C, Heagherty AM, Korsgaard N, Schiffrin EL, Heistad DD: Vascular remodeling. Hypertension 1996;28:505-506.
18. Mulvany MJ, Baandrup U, Gundersen HJG: Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional disector. Circ Res 1985;57:794-800.
19. Ledingham JM, Laverty R: Changes in structure of resistance arteries in the genetically hypertensive (GH) rat after treatment with losartan or felodipine. J Hypertens 1996; 14(suppl 1):S87.
20. 1 receptor subtype. Br J Pharmacol 1993;110:761-771.
21. Sachinidis A, Ko Y, Graack GKH. Wieczorck AJ, Vetter H: Action of metoprolol, enalapril, diltiazem, verapamil and nifedipine on cell growth of vascular smooth muscle cells. J Cardiovasc Pharmacol 1992;19(suppl 1):S60-S62.
22. Mulvany MJ, Halpern W: Contractile properties of small resistance arteries in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19-26.
23. Smirk FH, Hall WH: Inherited hypertension in rats. Nature 1958;182:727-728.
24. Maunsbach AB: The influence of different fixatives and fixation methods on the ultrastructure of rat kidney tubules. J Ultrastruct Res 1966;15:283-309.
25. Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N, Moller A. Nielsen K, Nyengaard JR, Pakkenberg B. Sorensen FB, Vesterby A, West MJ: Some new, simple and efficient stereological methos and their use in pathological research and diagnosis. APMIS 1988;96:379-394.
26. Gundersen HJG, Bagger P. Bendtsen TF, Evans SM. Korbo L, Marcussen N. Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, West MJ: The new stereological tools: Disector, fractionator, nueleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988;96:857-881.
27. Sterio DC: The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 1984;134:127-136.
28. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ: Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 1994;23:659-666.
29. Shaw LM, George PR, Oldham AA, Heagherty AM: A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries. J Hypertens 1995;13:1135-1143.
30. Baumbach GL, Heistad DD: Remodelling of cerebral arterioles in chronic hypertension. Hypertension 1989;13:968-972.
31. Harris EL. Phelan EL. Thompson CM, Millar JA, Grigor MR: Heart mass and blood pressure have separate genetic determinants in the New Zealand genetically hypertensive (GH) rat J Hypertens 1995;13:397-404.
32. Harrap SB, Van der Merwe WM, Griffin SA, Macpherson F, Lever AF: Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990; 16:603-614.
33. Harrap SB, Mitchell GA, Casley DJ, Mirakian S, Doyle AE: Angiotensin II, sodium, and cardiovascular hypertrophy in spontaneously hypertensive rats. Hypertension 1993;21:50-55.
34. Adams MA, Bobik A, Korner Pl: Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats. Hypertension 1990;16:252-260.
35. Christensen KL, Jespersen LT, Mulvany MJ: Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens 1989;7:83-90.
36. Korsgaard N, Christensen KL, Mulvany MJ: Cellular morphology in mesenteric resistance vessels from antihypertensive treated spontaneously hypertensive rats. Basic Res Cardiol 1991;86(suppl 1):33-41.
37. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ: Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 1994;23:659-666.
38. Rizzoni D, Porteri E, Piccoli A, Castellano M, Bettoni G, Muiesan ML, Pasini G, Guelfi D, Mulvany MJ, Agabiti Rosei H: Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension 1998;32:305-310.
39. Morton JJ, Beattie EC, MacPherson F: Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: Lack of relation to vascular structure. J Vas Res 1992;29: 264-269.
40. Soltis EE: Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats. J Pharmacol ExpTher 1993;266:642-646.
41. Ledingham JM, Phelan EL. Cross M, Laverty R: Effect of felodipine treatment and withdrawal on blood pressure and cardiovascular structure in New Zealand genetically hypertensive (GH) rats. Clin Exp Pharmacol Physiol 1995;22(suppl 1):S326-S328.
42. Nyborg NCB, Mulvany MJ: Lack of effect of anti-hypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats. Cardiovasc Res 1985;19: 528-536.
43. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabitei-Rosei E: Delayed development of hypertension after short-term nitrendipine treatment. Hypertension 1994;24: 131-139.